Navigation Links
10th Functional Genomics: Chemical Biology 2009
Date:8/21/2009

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

In the field of chemical biology, chemists and biologists cooperate to investigate, and eventually control, the behavior of cells. The scientists use small molecules that activate certain proteins to study how cells communicate, and ultimately they want to be able to prevent disease-causing interactions and understand how medicines and environmental toxins work on a cellular level.

The potential applications of research in chemical biology are unlimited. A number of serious diseases that lack effective treatments are currently being studied. Many of them will be discussed on 24-25 August when the University of Gothenburg and Chalmers University of Technology host the Functional Genomics/Chemical Biology conference in Gothenburg, Sweden:

  • Professor Carsten Schultz from the European Molecular Biology Laboratory (EMBL) in Heidelberg is developing new tools that will help us better understand cystic fibrosis. By visualising how cell signaling goes awry, Schultz hopes to come closer to finding a treatment for the incurable disease.

  • Ronald Raines from the University of Wisconsin has designed a 'Trojan horse' - an enzyme that infiltrates and then attacks the viruses that cause HIV and the lung disease SARS.

  • Guri Giaever from the University of Toronto uses yeast to investigate the action mechanism of medicines. Giaver is working together with pharmaceutical companies to explore and eliminate side effects of medicines.

  • Henrik Pavia is a University of Gothenburg marine ecologist and an expert in how marine organisms produce and utilise chemical substances. At the conference, Pavia will share the latest knowledge on how these marine bioactive substances can be used to create medicines for humans.

The conference, held at the Chalmers Conference Centre, will also present new findings about environmental toxins and the research currently carried out to identify how molecules in the cell are affected by the toxins.


'/>"/>

Contact: Per Sunnerhagen
per.sunnerhagen@cmb.gu.se
46-070-529-4180
University of Gothenburg
Source:Eurekalert

Related biology news :

1. Researchers expand efforts to explore functional landscape of the human genome
2. The endocannabinoids: Functional roles and therapeutic opportunities
3. RevGenUK, a single-stop shop for use in functional genomics
4. Junk DNA proves functional
5. Researchers generate functional neurons from somatic cells
6. ADA releases updated position statement on functional foods
7. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
8. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
9. Thermochemical process converts poultry litter into bio-oil
10. New chemically-sensitive MRI scan may bypass some invasive diagnostic tests in next decade
11. Natural chemical found in broccoli helps combat skin blistering disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
Breaking Biology Technology: